Certificates available

Click to access the printing area!


   On Demand Access

Click to access the event videos!


ATTENTION: The Brazilian Government has postponed the need for Australian, Canadian and American citizens to have a valid Visa to enter Brazil from April 10th 2024
to April 9th, 2025. Click here for more information.

Scientific Program

Important: SATELLITE SYMPOSIAS are activities carried out under the responsibility of the sponsoring company and which follow their respective compliance rules. Access is mostly exclusive to prescribers, exceptions will be informed in the scientific program.
Thursday, June 27, 2024


• Room 1 - Alfredo Halpern
08:00-09:30
SESSION: THE LANCET COMMISSION ON THE DEFINITION OF CLINICAL OBESITY: BACKGROUND, OBJECTIVES AND PROGRESS REPORT
Coordinator: Eric Ravussin (United States)

15 | Background to the Lancet Commission
Speaker: Ricardo Vitor Cohen (SP)

15 | The pathophysiology of obesity as a discrete disease
Speaker: Carel Le Roux (Ireland)

15 | BMI as a clinical and epidemiological instrument
Speaker: Ricardo Vitor Cohen (SP)

15 | BMI and obesity considerations in paediatric populations
Speaker: Louise Baur (Australia)

30 | Discussion
09:30-10:30
KEYNOTE LECTURE: ENERGY EXPENDITURE DURING THE LIFE COURSE AND IN THE LAST DECADES

Duração: 45 min.
Speaker: Eric Ravussin (United States)

15 | Discussion
10:30-11:00
BREAK
11:00-12:30
SESSION: DIETS IN OBESITY

08 | Abstracts - 129030: ENERGY INTAKE ESTIMATION FROM EATING SENSOR DATA WITH THE AUTOMATIC INGESTION MONITOR V2 (AIM-2) - Presenter: Edward Sazonov
20 | Diet wars: unveiling the carbohydrate-insulin model and energy balance model
Speaker: Kevin D. Hall (United States)

20 | Ketogenic diets: friend or foe?

20 | Intermittent fasting and Time Restrictive Feeding: is it superior to caloric restriction?
Speaker: Eric Ravussin (United States)

22 | Discussion
12:30-14:00
BREAK
14:00-15:30
SESSION: HETEROGENEITY IN RESPONSES TO OBESITY TREATMENT
Coordinator: Bruno Geloneze (SP)
Coordinator: Silvana Pannain (United States)

8 | Abstracts - 129737: INCREASING GLP1-RA EFFICACY BY TARGETING NON-CODING RNA: A COMBINATORY APPROACH TO DEVELOP A MORE EFFECTIVE THERAPEUTIC PARADIGM - Presenter: Riccardo Panella
20 | Predictors of weight loss in incretin-based therapies
Speaker: Deborah B. Horn (United States)

20 | What have we learned about the role of genetics in predicting response to obesity interventions?
Speaker: Fernando Gerchman (RS)

20 | Energy compensation, metabolic adaptation and physical activity
Speaker: Kevin D. Hall (United States)

22 | Discussion
16:30-18:00
CONTROVERSIES: IS THERE SUCH THING AS METABOLICALLY HEALTHY OBESITY?
Coordinator: Renan Montenegro Jr. (CE)

Abstracts - 129733: THE METABOLICALLY HEALTHY OBESITY PHENOTYPE HAS MORE ACTIVATION OF BROWN ADIPOSE TISSUE THAN THE METABOLICALLY UNHEALTHY OBESITY PHENOTYPE - Presenter: Isabela Solar
Abstracts - 128419: PREVALENCE AND TRENDS OF THE METABOLICALLY HEALTHY OBESE PHENOTYPE IN AN ARAB POPULATION - Presenter: Nasser Al-Daghri
Yes
Debater: Bruno Geloneze (SP)

No
Debater: José Silva - Nunes (Portugal)

• Room 2 - John Waterlow
08:00-09:30
SESSION: PATIENT REPORTED OUTCOMES MEASURES – IMPORTANCE IN CLINICAL PRACTICE AND RESEARCH
Coordinator: Andrea Levy (SP)

20 | How to measure quality of life improvement in clinical practice?

20 | ICHOM Set of Patient-Centred Outcome Measures for Adults living with Obesity
Speaker: Arya Sharma (Canada)

20 | Treating obesity beyond weight loss: what matters more for patients?
Speaker: Amber Huett-garcia (United States)

30 | Discussion
09:30-10:00
BREAK
10:00-11:00
MINI CONFERENCE

30 | The role of Intensive Behaviour treatment with new generation anti-obesity medications
Speaker: Nicholas Finer (United Kingdom)

30 | Tryglycerides and CVD residual risk reduction: is obesity the missing link?
Speaker: Raul Santos (SP)
11:00-12:30
SYMPOSIUM: ADDRESSING OBESITY DURING THE LIFE COURSE - PART 1

20 | Treating obesity before and during pregnancy – is it possible to reduce obesity risk in the offspring?

20 | Interventions in early childhood to prevent obesity
Speaker: Louise Baur (Australia)

20 | Managing obesity in adolescents: balancing metabolic benefits and potential psychological harms
Speaker: Louise Baur (Australia)

30 | Discussion
12:30-13:30
SATELLITE SYMPOSIUM - LILLY : RESTRICTED TO PRESCRIBERS
1 - Is BMI sufficient to diagnose and classify obesity? What options do we have?
Speaker:CINTIA CERCATO

2 - Ectopic and visceral fat: what is the real impact?
Speaker: CYNTHIA VALÉRIO
14:00-15:30
SYMPOSIUM: ADDRESSING OBESITY DURING THE LIFE COURSE - PART 2
Coordinator: Cintia Cercato (SP)

08 | Abstracts - 129738: BAT DYSFUNCTIONALITY AND DYSMETABOLISM IN DIFFERENT DEGREES OF ADIPOSOPATHY - Presenter: Maria Eduarda Martelli
20 | Addressing and managing metabolic associated hypogonadism in men
Speaker: Alexandre Hohl (SC)

20 | Menopause: A Fat-driven Cardiometabolic Transition
Speaker: Ada Cuevas (Chile)

20 | Treating obesity in the elderly: insights from LOOK AHEAD
Speaker: Donna Ryan (United States)

22 | Discussion
15:30-16:30
REFRESHMENT BREAK AND POSTER SESSION
16:30-18:00
WILLENDORF AND WERTHEIMER AWARD LECTURES
Moderator: Donna Ryan (United States)

Teaching Ravens to Fly Underwater
Speaker: Nicholas Finer (United Kingdom)

The Protein Leverage Hypothesis
Speaker: David Raubenheimer (Australia)

• Room 3 - Bernard Jeanrenaud
08:00-09:30
SESSION: WEIGHT CYCLING
Coordinator: Rodrigo Nunes Lamounier (MG)

8 | Abstracts - 129084: SERVICE EVALUATION OF A TIER 3, INTEGRATED WEIGHT MANAGEMENT PATHWAY USING SAXENDA (LIRAGLUTIDE) AND ITS IMPACT ON REDUCING CARDIOVASCULAR RISK FACTORS FOR PEOPLE LIVING WITH OBESITY - Presenter: Sophie Edwards
20 | Animal models of weight cycling
Speaker: Marciane Milanski (SP)

20 | Epidemiology of weight cycling and comorbidities: correlation or causation?

20 | Weight cycling with newer AOMs: a new concern?

22 | Discussion
09:30-10:00
BREAK
10:00-11:00
MINI CONFERENCE
Coordinator: Elaine Maria Frade Costa (SP)

30 | Microbiota and obesity: what do we know and what we don´t know

30 | Air pollution as a risk factor for metabolic diseases
11:00-12:30
SYMPOSIUM: SBEM-ABESO
Coordinator: Larissa Garcia Gomes (SP)

20 | Precocious puberty/ precocious adrenarche and the risk of obesity
Speaker: Cristiane Kochi (SP)

20 | The role of leptin in sexual maturation and fertility

20 | Endocrine Disruptors and obesity: where the evidence stands now?

30 | Discussion
12:30-13:30
SATELLITE SYMPOSIUM - MERCK: (RESTRICTED TO PRESCRIBERS)
One Size Does Not Fit All - The New Era of Obesity Management: Beyond Weight Loss
Palestrante: SEAN WHARTON
Palestrante: DANIEL MARTINEZ
Palestrante: ALEXANDER KOGLIN BENCHIMOL
14:00-15:30
SESSION: BROWN ADIPOSE TISSUE
Coordinator: Jose Donato Junior (SP)

08 | Abstracts - 128942: BREASTFEEDING, BROWN ADIPOSE TISSUE AND IL10: IMPACT ON THE THERMOGENESIS OF NEONATES - Presenter: Bruna Bombassaro
20 | microRNAs and the regulation of brown adipose tissue

20 | New mechanistic insights on the control of brown fat function and identity

20 | BAT and circadian rhythms

22 | Discussion
15:30-16:30
REFRESHMENT BREAK AND POSTER SESSION
16:30-17:30
MEET THE EXPERT: MULTIDISCIPLINARY APPROACH TO CHILDHOOD OBESITY
Coordinator and speaker: Louise Cominato (SP)
Speaker: Andrea Levy (SP)
17:30-18:30
MEET THE EXPERT: OBESITY TREATMENT IN POPULATION WITH LOWER INCOME
Coordinator: Fábio Ferreira de Moura (PE)
Speaker: Maria Edna de Melo (SP)

• Room 4 - Peter Kopelman
08:00-09:30
SESSION: OBESITY IMPACT ON OTHER ORGANS
Coordinator: Luciano Ferreira Drager (SP)

08 | Abstracts - 128804: MOLECULAR CHARACTERISATION OF OBESITY BY MEASURING METABOLOMIC CHANGES AFTER WEIGHT LOSS - Presenter: Madeleine L Smith
20 | Obesity nephropathy: what do we know about it?
Speaker: Niels Olsen Camara (SP)

20 | Obesity, cognitive decline and dementia: mechanisms of neurodegeneration and new insights

20 | The impact of obesity on lung diseases: much more than Sleep Apnea
Speaker: Geraldo Lorenzi Filho (SP)

22 | Discussion
09:30-10:30
SESSION: OBESITY, DIETS AND PLANETARY HEALTH
Coordinator: Barry Popkin (United States)

20 | Population strategies, diet, physical activity, and the environment for the prevention of obesity and NCD´s
Speaker: Carolina Batis (Mexico)

20 | Changes to food systems to reduce obesity and minimize the impacts on the natural Earth system
Speaker: Juan Rivera (Outro País)

20 | Discussion
10:30-11:00
BREAK
11:00-12:30
SYMPOSIUM: HOT TOPIC IN BARIATRIC SURGERY
Coordinator: Cid Araujo Pitombo (RJ)

08 | Abstracts - 128849: LONG-TERM EFFECT OF METABOLIC-BARIATRIC SURGERY ON MORTALITY AND MACRO AND MICROVASCULAR OUTCOMES IN ADULTS WITH OBESITY, METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, AND DIABETES - Presenter: Arunkumar Krishnan
20 | Endoscopic procedures for primary management of obesity and after bariatric surgery – a review of the evidence
Speaker: Vitor Brunaldi (SP)

20 | A critical appraisal of bariatric surgery in the elderly
Speaker: Denis Pajecki (SP)

20 | BS, alcohol and opioid abuse
Speaker: Adriano Segal (SP)

22 | Discussion
12:30-14:00
BREAK
14:00-15:30
SESSION: ULTRA-PROCESSED PRODUCTS CONSUMPTION AND OBESITY IN A GLOBALISED FOOD SYSTEM
Coordinator: Carlos Augusto Monteiro (SP)

Duração: 20 min.

20 | Accelerating global public health responses to rethink governance in food systems for UPF-control
Speaker: Simon Barquera (Mexico)

Duração: 20 min.
Speaker: Camila Corvalan (Chile)

30 | Discussion
15:30-16:30
REFRESHMENT BREAK AND POSTER SESSION
16:30-17:30
MEET THE EXPERT: SWITCHING DRUGS IN OBESITY TREATMENT: IN WHOM, WHEN AND HOW?
Speaker: Deborah B. Horn (United States)
17:30-18:30
MEET THE EXPERT: MANAGING LONG TERM COMPLICATIONS OF BARIATRIC SURGERY
Coordinator and speaker: Jacqueline Rizzolli (RS)

• Room 5 - Phillip James
08:00-09:30
SESSION: THE HEALTH SYSTEM RESPONSE TO THE OBESITY EPIDEMIC
Coordinator: Guilherme Nafalski (SP)

12 | Intersectoral and multistakeholder approach, with the participation of people with lived experience, as a way out of the obesity pandemic
Speaker: Mark Barone (SP)

12 | HIV as a model of care for obesity in the health systems
Speaker: Nomathemba Chandiwana (South Africa)

12 | The health system response to the obesity epidemic
Speaker: Jorgen Johnsen (Switzerland)

12 | Health service delivery framework for obesity care: an integrated, interprofessional, and network approach

12 | Integrating lived experience in rethinking obesity treatment in Latin America
Speaker: Maria Eugenia Anselmi (Argentina)

30 | Discussion
09:30-10:30
MAIN CONFERENCE: NEUROBIOLOGY OF EATING BEHAVIOR
Coordinator: Fernando Gerchman (RS)

45 | Molecular and functional genetics of food intake regulation in times of an obesity pandemic
Speaker: Marcelo Rubinstein (Argentina)

15 | Questions
10:30-11:00
BREAK
11:00-12:30
SESSION: HEALTH TAXES, LABELLING AND ADVANCING A REGULATORY AGENDA FOR OBESITY
Coordinator: Boyd Swinburn (New Zealand)

20 | Health taxes and policies
Speaker: Barry Popkin (United States)

20 | Marketing and labelling
Speaker: Camila Corvalan (Chile)

20 | School feeding, environments and PNAE

30 | Discussion
12:30-14:00
BREAK
14:00-15:30
SESSION: OBESITY AND TYPE 1 DIABETES
Coordinator: Roberto Zagury (RJ)
Coordinator: Rodrigo Nunes Lamounier (MG)

08 | Abstracts - 128844: DOES OBESITY CONFER A DIFFERING RISK ON PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES VERSUS TYPE 2 DIABETES? NOVEL DATA FROM AN AUSTRALIAN RETROSPECTIVE STUDY (2010-2019) COMPARING PREGNANCY OUTCOMES STRATIFIED BY BMI CATEGORY IN WOMEN WITH PREGE - Presenter: Xi May Zhen
20 | Size of the problem and using nutrition therapy and exercise therapy for people living with obesity and type 1 diabetes
Speaker: Carel Le Roux (Ireland)

20 | Pharmacotherapy for people living with obesity and type 1 diabetes
Speaker: Ebaa Al Ozairi (Kuwait)

20 | Surgical therapy for people living with obesity and type 1 diabetes
Speaker: Ricardo Vitor Cohen (SP)

22 | Discussion
15:30-16:30
REFRESHMENT BREAK AND POSTER SESSION
16:30-18:30
SESSION: ADVANCING COMMUNITY-BASED CHILDHOOD OBESITY PREVENTION IN CITIES
Moderator: Simon Barquera (Mexico)

Opening: Prevention of childhood obesity through community interventions and the role of cities (WOF)
Keynote: Shaping healthy urban neighbourhoods for children
Speaker: Gil Penalosa (Canada)

Breakout session: Identifying barriers and solutions to co-creating community-based interventions
Panel: What does it take to shape healthy city environments for children?
Panelist: Jo Jewell (Denmark)
Panelist: Henrique Goes (Brazil)
Panelist: Marina Arilha Silva (Brazil)
Panelist: Stephanie Amaral (DF)

Closing
Speaker: Gil Penalosa (Canada)

• Room 6 - Rafael Gomez-Cuevas
08:00-09:30
FLASO MEETING: OBESIDAD: FACTORES ETIOLÓGICOS Y COMPLICACIONES (EN ESPAÑOL)
*Activity supported by Novo Nordisk
Coordinator: Rafael Figueiredo (Paraguay)

20 | Alteraciones del microbioma y obesidad: de la teoría a la relevancia práctica

20 | La Fisiología del Tejido Adiposo y supervivencia según el contexto ambiental
Speaker: Julio C Montero (Argentina)

20 | Obesidad y cáncer
Speaker: Raquel Franco Nuñez (Outro País)

20 | El aporte profesional al estigma de la obesidad: una conversación global
Speaker: Adela González Barnech (Uruguay)

10 | Discusion
09:30-10:30
FLASO MEETING: OBESIDAD: ENFOQUE DEL TRATAMIENTO (IN SPANISH)
*Activity supported by Novo Nordisk
Coordinator: Rafael Figueiredo (Paraguay)

20 | Obesidad: ¿estamos en el camino correcto?
20 | Insuficiencia cardiaca y manejo cardiometabólico. Una visión desde la Endocrinología
Speaker: Elvio Bueno (Paraguay)

20 | El riesgo cardiorrenal metabolico
10:30-11:00
BREAK
11:00-12:30
FLASO MEETING: TRATAMIENTO DE LA OBESIDAD (EN ESPAÑOL)
*Activity supported by Novo Nordisk
Coordination: Rafael Figueiredo (Paraguay)

20 | Enfermedad hepática y Cirugía Bariátrica
Speaker: Mariana Elhordoy Carvallo (Uruguay)

20 | aGLP-1, punto de encuentro del tratamiento de la diabesidad
Speaker: Paul Camperos (Venezuela, RB)

20 | Terapia con fármacos combinados en el manejo de la obesidad
Speaker: Hernan Yupanqui Lozno (Colombia)

20 | Presente y futuro del tratamiento farmacológico de la obesidad
Speaker: Bruno Halpern (SP)
12:30-14:00
BREAK
14:00-15:30
SESSION: ABSTRACTS - BASIC SCIENCE
Judge: Marciane Milanski (SP)

128786 - THE EFFECTS OF PHOSPHODIESTERASE 4 INHIBITORS ON WEIGHT LOSS AND ENERGY HOMEOSTASIS IN MICE WITH OBESITY INDUCED BY A HIGH-FAT-DIET
129100 - THE ROLE OF MIR-146A E MIR-378 ON C/EBP-Β, IN OBESE INSULIN SENSITIVITY IMPROVEMENT, INDUCED BY PHYSICAL EXERCISE
129583 - EXPLORING THE CULINARY SKILLS AND DIET QUALITY ACROSS DIFFERENT CARDIOMETABOLIC PHENOTYPES: INSIGHTS FROM THE MENU PROJECT - CULINARY MEDICINE AND NUTRITION
129307 - THE GLOBAL DIET QUALITY SCORE WAS ASSOCIATED WITH BODY ADIPOSITY INDICATORS IN PARTICIPANTS OF THE NUTRITIONIST’S HEALTH STUDY - NUTRIHS
CagriSema driven weight loss in diet-induced obese rats depends on counter-regulation of weight loss associated reduction in energy expenditure
15:30-16:30
REFRESHMENT BREAK AND POSTER SESSION
16:30-17:30
THE IMPACT OF OBESITY TREATMENT BEYOND WEIGHT LOSS
Speaker: João Eduardo Nunes Salles (SP)

• Poster Area - Per Bjorntorp
15:30-16:30
REFRESHMENT BREAK AND POSTER SESSION
E-poster 1

E-poster 2

E-poster 3


Venue



Centro de Convenções Frei Caneca
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001




website   ACCOMMODATION
FOLLOW US
ICO 2024
   

PROMOTED BY

MANAGEMENT


Tourism Agency



DIAMOND SPONSOR

GOLD SPONSOR

BRONZE SPONSOR

SPONSOR